Fed. Circ. Backs Ban On Generic Treximet
The appeals court said a Texas federal court had made no errors when it declared Pozen's patents legitimate last year, meaning Par Pharmaceutical Cos., Alphapharm Pty Ltd. and Dr. Reddy’s Laboratories Ltd. are still banned from selling their generic versions.
Treximet, created by Pozen in collaboration with GlaxoSmithKline PLC, is a combination of...
To view the full article, register now.